Most recently, it's been determined that conolidine and the above mentioned derivatives act to the atypical chemokine receptor three (ACKR3. Expressed in identical areas as classical opioid receptors, it binds to some wide array of endogenous opioids. In contrast to most opioid receptors, this receptor acts as being a scavenger and doesn't activate